Hikma buys rights to FDA-approved cancer treatment trametinib, a generic version of Novartis' (NVS) Mekinist, with 180 days ...

European drugmaker Novartis (NVS), best known for blockbuster drugs like Entresto, Cosentyx, and Kesimpta, just announced a major U.S.

TGTX surges 200% in 2023 on Briumvi's MS success. With Q1'25 earnings ahead, see here for TGTX stock's sales trends, new ...

Bill Gates became the youngest billionaire back in 1987 when he took Microsoft public, and he has been a billionaire since ...

I was at Novartis headquarters in Basel yesterday for the company’s Q4 results, and my burning question was – did the company have any designs on entering the viral vector-based gene therapy ...

Featured Earnings W. R. Berkley Corporation (NYSE:WRB) (Q1) EPS of $1.01, compared to $1.04 in the prior-year quarter.

Entrepreneurial CMO 50 list recognizes fifty chief marketers whose approach to driving growth is charting new paths.

Vas Narasimhan is global head of drug development and chief medical officer at Novartis, and spoke to pharmaphorum at the company’s recent Q4 results conference. He says numerous pilot studies ...

We recently published a list of Bill Gates’ 10 Stock Positions with Huge Upside Potential. In this article, we are going to ...

Stifel head of biotech research Paul Matteis suggests looking for biotech names not dependent on the FDA while this sector ...

USA News Group News Commentary – Routine medical appointments or cancer screening rates—an important aspect in increasing ...